After major changes, Grand Erie health unit seeks new identity, leaders
It turns out
merging
was the easy part for one of Ontario's
newest health units.
Since Grand Erie Public Health was created in January from the merger of health units in
Haldimand-Norfolk
and Brantford-Brant, the new organization has appointed three different
medical officers of health
and is now
without a CEO,
all while managing one of the province's largest
measles outbreaks.
Staff at the health unit — which formed after the province put out a call for voluntary mergers last year — are also trying to figure out which services are most needed across a large and diverse coverage area.
The health unit recently launched a survey asking residents to share their past experiences interacting with public health and to define what public health means to them.
The survey also asks respondents what values they associate with their local health unit, what health unit services they have used, and the methods of communication are most effective at passing on health information.
The questionnaire will be used to create a new 'brand voice' and communication strategy for the health unit, according to a message to survey respondents.
The former Haldimand-Norfolk Health Unit conducted public surveys before and after the COVID-19 pandemic. Among the main findings were the need for the health unit to be more transparent and
rebuild trust
with residents who were left mistrustful or even fearful of public health due to poor communication and the debates over vaccinations and lockdowns.
The current survey — which is completed anonymous — is available online at
geph.ca
until May 25.
Who will lead the health unit remains an open question after the departure of CEO Brent Richardson in April.
Richardson joined Brant County Health Unit in 2017 and became CEO in 2022.
The health unit did not explain why Richardson left, and he did not respond to a request for comment from The Spectator.
A search is underway for his replacement, led by corporate recruiter LHH Knightsbridge.
According to the online
job posting,
the ideal candidate will be 'financially savvy' and a 'politically astute communicator' who 'fosters trust, transparency and inclusion.'
'We are seeking an inspiring and innovative leader — someone deeply committed to public service excellence and community well-being,' board of health chair Amy Martin said in a statement.
'This is a unique and exciting opportunity to shape the future of our newly merged organization and lead transformative change for the communities we serve.'
The new CEO will report to the board and work closely with the medical officer of health, a position currently held by
Dr. Adelle Chang On,
who temporarily left her public health role in Waterloo Region to fill in as Grand Erie's top doc following the death of Dr. Malcolm Lock in February.
Lock himself was a fill-in for Dr. Rebecca Comley, who was announced as Grand Erie's acting medical officer of health after the merger in January but took a leave of absence soon after.
The health unit also has a
job posting
open for a permanent medical officer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
41 minutes ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Yahoo
an hour ago
- Yahoo
2 new measles cases announced in Colorado: Exposure locations, current number of cases
DENVER (KDVR) — Two new measles cases have been announced in Colorado, this time in El Paso and Arapahoe counties. The Colorado Department of Public Health and Environment said in the El Paso County case, a child under the age of 5 years old has a confirmed case of measles after traveling with family to Ontario, Canada, where there is an ongoing measles outbreak. The child has one dose of the measles, mumps and rubella vaccine, CDPHE said. Measles outbreaks in Michigan and Pennsylvania end, while Texas logs just 4 new cases The second case involves an unvaccinated Arapahoe County adult. The person was at Denver International Airport on Tuesday, May 13, which is during the exposure period from a Turkish Airlines passenger who flew while infectious and landed at DIA. This brings the total number of measles cases to 14 in the state, with Arapahoe, Denver and El Paso counties each having four cases, and Pueblo and Archuleta counties each having one. Here are the possible exposure locations for measles from the newly announced cases. Anyone who was there should monitor for symptoms for 21 days after exposure and avoid public gatherings or high-risk settings. Location Date/time When symptoms may develop Powers Pointe Urgent Care5607 Barnes RoadColorado Springs, CO 80917 Tuesday, June 39:30 a.m. – 12:30 p.m. Through June 24 HCA HealthONE Aurora (Medical Center of Aurora) Emergency Department1501 S. Potomac CO 80012 Thursday, June 54:55 – 10:05 p.m. Through June 26 Safeway1200 S. Buckley RoadAurora, CO 80017 Friday, June 64 – 6:15 p.m. Through June 27 St. Francis Medical Center Emergency Department6001 E. Woodmen RoadColorado Springs, CO 80923 Saturday, June 79:30 – 10:50 a.m. Through June 28 UCHealth University of Colorado Hospital Emergency Department12605 E. 16th CO 80045 Saturday, June 72 – 4:10 p.m. Through June 28 There are further exposure locations in Aurora, Colorado Springs, Denver, Evergreen, Glendale, Grand Junction, Greenwood Village and Windsor. All locations and time frames have been listed on CDPHE's website here. Anyone who was at the above locations during the exposure window and develops symptoms should immediately contact their health provider by phone. If you do not have a provider, call urgent care or an emergency department and explain your measles exposure. Calling ahead helps limit further exposures. Measles vaccination rates drop after COVID-19 pandemic in counties across the US Measles is highly contagious and can spread through the air via coughs and sneezes. The disease can remain in the air up to two hours after the person has left. The best way to protect yourself and your loved ones is through the MMR vaccine, according to CDPHE. Two doses of the MMR vaccination are about 97% effective in preventing measles, CDPHE has repeatedly stated. 'In rare cases, people who are vaccinated can still get measles, but their symptoms are usually milder, and they are less likely to spread it to others,' CDPHE explained in a release. About 93.7% of Colorado children have the MMR vaccination, which protects against measles, mumps, rubella and varicella. That's below the goal threshold of 95% for community immunity. Coloradans can check their own or their child's immunization records through the state's Immunization Information System public portal. If your provider has not reported vaccines, some records may be incomplete. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant, NB.1.8.1, spreads across the globe. Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UK Health Security Agency recorded the first 13 cases in England last week. But the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago. NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year. It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia. By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent a month before. The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus. Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants. 'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation. Dr Chun Tang, GP at UK private healthcare centre Pall Mall Medical, said: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity. 'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.' 'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice. 'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.' However, the 'Nimbus' variant, as it has been dubbed, does appear to be more transmissible than previous strains, with notable increases reported in India, Hong Kong, Singapore and Thailand, notes Dr Asif. Common symptoms of Nimbus include a severe sore throat, fatigue, mild cough, fever, muscle aches and congestion. It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea. Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
